Upgrade to SI Premium - Free Trial

Medtronic, Inc. (MDT) PT Lowered to $106 at Oppenheimer

August 24, 2022 8:06 AM
Oppenheimer analyst Steven Lichtman lowered the price target on Medtronic, Inc. (NYSE: MDT) to $106.00 (from $115.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Analyst PT Change

Next Articles